AI Verdict
LCII has stronger fundamentals based on our AI analysis.
LCTX vs LCII Fundamental Comparison
| Metric | LCTX | LCII |
|---|---|---|
| Revenue | $14.6M | $4.1B |
| Net Income | $-63.5M | $188.3M |
| Net Margin | -436.5% | 4.6% |
| ROE | -142.6% | 13.8% |
| ROA | -56.4% | 5.9% |
| Current Ratio | 5.20x | 2.85x |
| Debt/Equity | 0.00x | 0.69x |
| EPS | $-0.28 | $7.57 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LCTX vs LCII: Frequently Asked Questions
Is LCTX or LCII a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LCII has stronger fundamentals. LCTX is rated SELL (88% confidence) while LCII is rated BUY (78% confidence). This is not investment advice.
How does LCTX compare to LCII fundamentally?
Lineage Cell Therapeutics, Inc. has ROE of -142.6% vs LCI INDUSTRIES's 13.8%. Net margins are -436.5% vs 4.6% respectively.
Which stock pays higher dividends, LCTX or LCII?
LCTX has a dividend yield of N/A or no dividend while LCII has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LCTX or LCII for long term?
For long-term investing, consider that LCTX has SELL rating with 88% confidence, while LCII has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LCTX vs LCII?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LCTX vs LCII, the AI consensus favors LCII based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.